Injections, Intralesional

"Injections, Intralesional" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Injections introduced directly into localized lesions.

Descriptor ID	D015552
MeSH Number(s)	E02.319.267.530.430
Concept/Terms	Injections, Intralesional Injections, Intralesional Intralesional Injections Injection, Intralesional Intralesional Injection

Below are MeSH descriptors whose meaning is more general than "Injections, Intralesional".

Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
Therapeutics [E02]
Drug Therapy [E02.319]
Drug Administration Routes [E02.319.267]
Injections [E02.319.267.530]
Injections, Intralesional [E02.319.267.530.430]

Below are MeSH descriptors whose meaning is related to "Injections, Intralesional".

Below are MeSH descriptors whose meaning is more specific than "Injections, Intralesional".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Injections, Intralesional" by people in this website by year, and whether "Injections, Intralesional" was a major or minor topic of these publications.

Bar chart showing 50 publications over 26 distinct years, with a maximum of 5 publications in 2017 and 2020

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1996	0	1	1
1997	0	2	2
1998	0	2	2
1999	0	3	3
2000	0	1	1
2001	0	1	1
2002	0	2	2
2003	0	1	1
2004	0	1	1
2005	0	2	2
2007	0	1	1
2008	0	1	1
2009	0	2	2
2010	0	1	1
2011	0	1	1
2012	0	4	4
2013	0	1	1
2014	0	3	3
2015	0	2	2
2016	1	2	3
2017	0	5	5
2018	0	2	2
2020	0	5	5
2022	0	1	1
2023	0	1	1
2024	1	0	1

Below are the most recent publications written about "Injections, Intralesional" by people in Profiles.

Arango SD, Weir TB, Miller AJ, Osterman MN. Skin necrosis following digital wart intralesional injection of cantharidin. Dermatol Online J. 2024 Oct 15; 30(5).

View in: PubMed
Pamonag MZ, Seery AM, Omari AIA, Alnouri G, Sataloff RT. Intralesional Cidofovir: A Systematic Review of Administration Protocols and Long-term Recurrence Rates in Adult and Juvenile Recurrent Respiratory Papillomatosis. J Voice. 2025 Nov; 39(6):1631-1640.

View in: PubMed
Cohen AJ, Talasila S, Lazarevic B, Banner L, Gleason L, Malkani K, Uitto J, Nikbakht N. Combination cryotherapy and intralesional corticosteroid versus steroid monotherapy in the treatment of keloids. J Cosmet Dermatol. 2023 Mar; 22(3):932-936.

View in: PubMed
Rivera KO, Russo F, Boileau RM, Tomlinson RE, Miclau T, Marcucio RS, Desai TA, Bahney CS. Local injections of ?-NGF accelerates endochondral fracture repair by promoting cartilage to bone conversion. Sci Rep. 2020 12 17; 10(1):22241.

View in: PubMed
Whited CW, Lubin J, Marka N, Koszewski IJ, Hoffman MR, Schoeff S, Dailey SH. Pain Experience and Tolerance of Awake In-Office Upper Airway Procedures: Influencing Factors. Laryngoscope. 2021 05; 131(5):E1580-E1588.

View in: PubMed
Pollack KE, Meneveau MO, Melssen MM, Lynch KT, Koeppel AF, Young SJ, Turner S, Kumar P, Sol-Church K, Mauldin IS, Slingluff CL. Incomplete Freund's adjuvant reduces arginase and enhances Th1 dominance, TLR signaling and CD40 ligand expression in the vaccine site microenvironment. J Immunother Cancer. 2020 04; 8(1).

View in: PubMed
Van Nest DS, Tjoumakaris FP, Smith BJ, Beatty TM, Freedman KB. Popliteal Cysts: A Systematic Review of Nonoperative and Operative Treatment. JBJS Rev. 2020 03; 8(3):e0139.

View in: PubMed
Shore N, Kaplan SA, Tutrone R, Levin R, Bailen J, Hay A, Kalota S, Bidair M, Freedman S, Goldberg K, Snoy F, Epstein JI. Prospective evaluation of fexapotide triflutate injection treatment of Grade Group 1 prostate cancer: 4-year results. World J Urol. 2020 Dec; 38(12):3101-3111.

View in: PubMed
Knorr DA, Dahan R, Ravetch JV. Toxicity of an Fc-engineered anti-CD40 antibody is abrogated by intratumoral injection and results in durable antitumor immunity. Proc Natl Acad Sci U S A. 2018 10 23; 115(43):11048-11053.

View in: PubMed
Shore N, Tutrone R, Efros M, Bidair M, Wachs B, Kalota S, Freedman S, Bailen J, Levin R, Richardson S, Kaminetsky J, Snyder J, Shepard B, Goldberg K, Hay A, Gange S, Grunberger I. Fexapotide triflutate: results of long-term safety and efficacy trials of a novel injectable therapy for symptomatic prostate enlargement. World J Urol. 2018 May; 36(5):801-809.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement